Prediction of blood volume to be processed to achieve a target number of CD34+ cells: Development, validation and implementation of a formula

Irene García‐García,Joan Cid,Gemma Moreno‐Jiménez,María Tenorio Núñez,Ana Jiménez Martín,Ana Vallés Carboneras,Kyra Velázquez‐Kennedy,Miquel Lozano,Francisco‐Javier López‐Jiménez
DOI: https://doi.org/10.1111/vox.13410
2023-02-06
Vox Sanguinis
Abstract:Background and Objectives Calculation of blood volume (BV) to be processed to achieve the target number of CD34+ cells can be accomplished by using collection efficiency 2 (CE2) formula. Our aim was to develop a BV web formula. Materials and Methods We calculated CE2 from aphereses performed between January 2015 and March 2020 in allogeneic donors and patients. From May 2020 to May 2021, we validated a formula: BV = ((Target CD34+ cells in the product)/(CD34+ pre‐apheresis cells × CE2)) × 100. Subsequently, we compared the outcome of the procedures carried out before formula implementation (pre‐formula), when standard three total BV collection was performed. Results CE2 was assessed in 384 apheresis procedures before formula implementation. CE2 was higher in allogeneic donors than in patients (53% ± 17% vs. 48% ± 15%, p = 0.008). CE2 was higher in multiple myeloma and non‐Hodgkin lymphoma than Hodgkin's lymphoma (48% ± 15%, 48% ± 15% and 42% ± 13%, respectively; p = 0.008). Our formula (available on a website: Publisheet) was prospectively used in 54 individuals. The formula was very accurate: predicted versus observed CD34 + cells/kg collected had an r‐value of 0.89 (p
hematology
What problem does this paper attempt to address?